Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Appold

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2011
Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancerMaria Hentschel, Steffen Appold, Andreas Schreiber, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|June 30, 2010
Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumorsAndrij Abramyuk, Gunter Wolf, Georgy Shakirin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
Dose-volume predictors of early esophageal toxicity in non-small cell lung cancer patients treated with accelerated-hyperfractionated radiotherapyRebecca Bütof, Steffen Löck, Maher Soliman, et al.
Lung Cancer (Amsterdam, Netherlands)|April 8, 2010
Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapyKornelia Szluha Lazanyi, Andrij Abramyuk, Gunter Wolf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trialMaher Soliman, Ala Yaromina, Steffen Appold, et al.
Nuklearmedizin. Nuclear Medicine|March 28, 2019
Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patientsAlexander Kohler, Steffen Löck, Steffen Appold, et al.
Plos One|December 21, 2018
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapyNils Cordes, Michael Ney, Thomas Beleites, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapyRebecca Bütof, Calogero Gumina, Chiara Valentini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2012
Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancerDaniel Zips, Klaus Zöphel, Nasreddin Abolmaali, et al.
Journal of Neuro-Oncology|September 14, 2022
Surgical results of 158 petroclival meningiomas with special focus on standard craniotomiesGabriele Schackert, Miriam Lenk, Matthias Kirsch, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Nuclear Medicine and Molecular Imaging|February 26, 2011
Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancerMaria Hentschel, Steffen Appold, Andreas Schreiber, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|June 30, 2010
Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumorsAndrij Abramyuk, Gunter Wolf, Georgy Shakirin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 27, 2019
Dose-volume predictors of early esophageal toxicity in non-small cell lung cancer patients treated with accelerated-hyperfractionated radiotherapyRebecca Bütof, Steffen Löck, Maher Soliman, et al.
Lung Cancer (Amsterdam, Netherlands)|April 8, 2010
Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapyKornelia Szluha Lazanyi, Andrij Abramyuk, Gunter Wolf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
GTV differentially impacts locoregional control of non-small cell lung cancer (NSCLC) after different fractionation schedules: subgroup analysis of the prospective randomized CHARTWEL trialMaher Soliman, Ala Yaromina, Steffen Appold, et al.
Nuklearmedizin. Nuclear Medicine|March 28, 2019
Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patientsAlexander Kohler, Steffen Löck, Steffen Appold, et al.
Plos One|December 21, 2018
Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapyNils Cordes, Michael Ney, Thomas Beleites, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapyRebecca Bütof, Calogero Gumina, Chiara Valentini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2012
Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancerDaniel Zips, Klaus Zöphel, Nasreddin Abolmaali, et al.
Journal of Neuro-Oncology|September 14, 2022
Surgical results of 158 petroclival meningiomas with special focus on standard craniotomiesGabriele Schackert, Miriam Lenk, Matthias Kirsch, et al.
Pageof 4